{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:08:59Z","timestamp":1749182939949,"version":"3.41.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"DOI":"10.13039\/501100013115","name":"Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents","doi-asserted-by":"crossref","award":["CZ-RC2022010"],"award-info":[{"award-number":["CZ-RC2022010"]}],"id":[{"id":"10.13039\/501100013115","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To assess the impact of bilateral vision status on vision-related quality of life (VR-QOL) in patients with Type 2 diabetes in a Chinese cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients with presenting visual acuity (PVA) and VR-QOL data from the Fushun Diabetic Retinopathy Cohort Study were included. Vision-related quality of life was assessed using the National Eye Institute Visual Function Questionnaire-25. Monocular PVA (Snellen) was categorized into three levels for both the better-seeing eye and worse-seeing eye: 1) high PVA (H, &gt; 6\/18); 2) moderate PVA (M, 6\/18\u20136\/60); and 3) low PVA (L, &lt; 6\/60). Based on the monocular PVAs, six categories of bilateral vision status were defined (H-H, H-M, H-L, M-M, M-L, and L-L). The parameters of VR-QOL were analyzed between the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 1,717 patients were enrolled. For better-seeing eyes in the same PVA level, the Visual Function Questionnaire-25 composite score decreased significantly with declining PVA in the worse-seeing eye (H-M vs. H-L: 80.5 \u00b1 17.9 vs. 73.6 \u00b1 22.5, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01; M-M vs. M-L: 78.7 \u00b1 19.6 vs. 69.1 \u00b1 26.4, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01). Conversely, for worse-seeing eyes in the same PVA level, there was no significant difference in the Visual Function Questionnaire-25 composite score as PVA changed in the better-seeing eye (H-M vs. M-M, 80.5 \u00b1 17.9 vs. 78.7 \u00b1 19.6, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.30; H-L vs. M-L: 73.6 \u00b1 22.5 vs. 69.1 \u00b1 26.4, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.25).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The PVA of the worse-seeing eye in bilateral vision has a greater impact on VR-QOL in diabetic patients. Priority treatment may be considered for the worse-seeing eye for diabetic patients with different bilateral vision statuses, to better improve VR-QOL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004047","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T22:08:14Z","timestamp":1704838094000},"page":"1021-1025","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["THE IMPACT OF BILATERAL VISION STATUS ON VISION-RELATED QUALITY OF LIFE IN PEOPLE WITH DIABETES MELLITUS"],"prefix":"10.1097","volume":"44","author":[{"given":"Zushun","family":"Lin","sequence":"first","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[{"name":"Fushun Eye Hospital, Fushun, Liaoning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wen","sequence":"additional","affiliation":[{"name":"Fushun Eye Hospital, Fushun, Liaoning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Fushun Eye Hospital, Fushun, Liaoning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Lin","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China; and"},{"name":"Fushun Eye Hospital, Fushun, Liaoning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"R3-20250605","first-page":"e19236","article-title":"Prevalence and risk factors of diabetic retinopathy in diabetic patients: a community based cross-sectional study","volume":"99","author":"Yin","year":"2020","journal-title":"Medicine (Madr)"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11892-016-0815-6","article-title":"Presence and risk factors for glaucoma in patients with diabetes","volume":"16","author":"Song","year":"2016","journal-title":"Curr Diab Rep"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1167\/iovs.17-22264","article-title":"Incidence, progression, and risk factors for cataract in type 2 diabetes","volume":"58","author":"Srinivasan","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00592-019-01384-9","article-title":"Vision-related quality of life and locus of control in type 1 diabetes: a multicenter observational study","volume":"56","author":"Trento","year":"2019","journal-title":"Acta Diabetol"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00592-013-0470-1","article-title":"Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study","volume":"50","author":"Trento","year":"2013","journal-title":"Acta Diabetol"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1167\/iovs.17-21945","article-title":"Evaluating the relationship between visual acuity and utilities in patients with diabetic macular edema enrolled in intravitreal aflibercept studies","volume":"58","author":"Brazier","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ophtha.2010.08.003","article-title":"Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study","volume":"118","author":"Mazhar","year":"2011","journal-title":"Ophthalmology"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1167\/iovs.16-20165","article-title":"Differential impact of unilateral and bilateral classifications of diabetic retinopathy and diabetic macular edema on vision-related quality of life","volume":"57","author":"Man","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archopht.119.5.733","article-title":"The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy","volume":"119","author":"Klein","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/ceo.12745","article-title":"Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review","volume":"44","author":"Lin","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09286586.2019.1680702","article-title":"Rationale, design, methodology and baseline data of Fushun diabetic retinopathy cohort study (FS-DIRECT)","volume":"27","author":"Wang","year":"2020","journal-title":"Ophthalmic Epidemiol"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0161-6420(13)38009-9","article-title":"Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7","volume":"98","author":"LZS","year":"1991","journal-title":"Ophthalmology"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/bjo.2009.158428","article-title":"Development of a Chinese version of the national eye Institute visual function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong","volume":"93","author":"Chan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12020-016-1097-0","article-title":"Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial","volume":"57","author":"Trento","year":"2017","journal-title":"Endocrine"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/DMSO.S343926","article-title":"The association of the prevalence of depression in type 2 diabetes mellitus with visual-related quality of life and social support","volume":"15","author":"Ding","year":"2022","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ophtha.2017.04.014","article-title":"Impact of first eye versus second eye cataract surgery on visual function and quality of life","volume":"124","author":"Shekhawat","year":"2017","journal-title":"Ophthalmology"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2147\/OPTH.S64200","article-title":"The impact of a better-seeing eye and a worse-seeing eye on vision-related quality of life","volume":"8","author":"Hirneiss","year":"2014","journal-title":"Clin Ophthalmol (Auckland, N.Z.)"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jamaophthalmol.2015.3426","article-title":"Relationships between measures of the ability to perform vision-related activities, vision-related quality of life, and clinical findings in patients with glaucoma","volume":"133","author":"Ekici","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/1388235039048690","article-title":"The AMA Guides functional vision score is a better predictor of vision-targeted quality of life than traditional measures of visual acuity or visual field extent","volume":"5","author":"Fuhr","year":"2003","journal-title":"Vis Impairment Res"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/OPX.0b013e3181e61a88","article-title":"Monocular vs. Binocular measurement of spatial vision in elders","volume":"87","author":"Schneck","year":"2010","journal-title":"Optom Vis Sci"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41598-020-79483-9","article-title":"Impacts of monocular, binocular, and functional visual acuity on vision-related quality of life in patients with type 2 diabetes","volume":"11","author":"Liao","year":"2021","journal-title":"Sci Rep"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ophtha.2013.12.032","article-title":"The impact of anti\u2013vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration","volume":"121","author":"Finger","year":"2014","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:03:32Z","timestamp":1749143012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004047","relation":{},"ISSN":["0275-004X"],"issn-type":[{"type":"print","value":"0275-004X"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}